Some of the world's largest private equity firms have struck partnerships with AI companies including OpenAI, Anthropic, and Google, aiming to push artificial intelligence into the hundreds of thousands of healthcare workers across their portfolio companies. The arrangements, which go beyond simple software purchases, give the firms financial incentives to require AI adoption at hospitals, home health agencies, dental chains, and revenue cycle management firms they already control - raising an old question in a new form: who benefits when efficiency gains arrive?
Where the partnerships hit healthcare
The private equity firms involved in these deals hold stakes in dozens of healthcare employers: LifePoint Health, BrightSpring/PharMerica, Global Medical Response, Aveanna Healthcare, AccentCare, ScionHealth, Aspen Dental, Heartland Dental, Surgery Partners, Athenahealth, Ensemble Health Partners, and others. Together they employ hundreds of thousands of people in nursing, home health, hospice, emergency services, physician practices, dental care, and the administrative machinery that supports them. Many of those roles - billing, scheduling, documentation, customer service - are the very ones companies now target for AI-driven productivity gains and restructuring.
Healthcare employers are already training workers on how to use these tools, and AI for Healthcare is no longer a niche concern. Nurses have inserted AI provisions into union contracts. Hospitals and insurers are deploying AI for documentation, workflow management, and patient communications. The debate is active, but the private equity firms orchestrating much of the adoption have stayed largely out of the conversation.
A financial track record worth examining
Private equity's history in healthcare offers reasons for scrutiny. Supporters argue that automation can reduce paperwork and let clinicians spend more time with patients. But the pattern of extracting returns before reinvesting in operations is well documented. Prospect Medical Holdings saw its private equity owners pull hundreds of millions of dollars out while hospitals struggled. Steward Health Care paid substantial sums to investors and completed financial transactions that enriched owners even as liabilities mounted and the system collapsed.
The same dynamic extends beyond hospitals. At Sevita, a major provider of services for people with intellectual and developmental disabilities, owners Centerbridge Partners and Vistria Group collected $100 million in 2019 and another $375 million in 2021 through dividend recapitalizations that loaded the company with debt. Regulators later warned that such practices could leave less money for staffing, training, and facility upkeep - the investments tied directly to quality of care.
The savings question nobody answered
When AI delivers savings, who captures them is not a question of technology; it is a question of ownership and control. The firms that negotiate these AI partnerships can push management teams across dozens of portfolio companies to adopt the same operational strategies. They can set targets for efficiency gains. And they have a direct financial interest in seeing those gains returned to investors, not necessarily to staffing ratios, facility upgrades, or lower patient costs.
Even if AI does reduce costs, implementation is expensive. Recent experience across industries shows that software, training, compliance, and ongoing oversight require significant investment. The net effect on a healthcare company's budget is not guaranteed. Yet the decision about where any surplus goes - back into the business or out to investors - will be made by the same people who structured the partnerships.
Why this matters for healthcare workers
If you work for a healthcare company connected to one of these private equity firms, do not wait until new AI tools appear on your unit or in your department to start asking questions. Ask now how success will be measured, whether any savings will be reinvested in patient care and staffing, and who stands to benefit if those savings materialize. The promises of efficiency have been made before. The answer to "who benefits" has often been found in the financial disclosures, not in the clinical outcomes.
Your membership also unlocks:
